[Federal Register: April 7, 1999 (Volume 64, Number 66)]
[Notices]               
[Page 16998-16999]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07ap99-109]

-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-814 (Preliminary)]

 
Creatine Monohydrate From the People's Republic of China

Determination

    On the basis of the record <SUP>1</SUP> developed in the subject 
investigation, the United States International Trade Commission 
determines, pursuant to section 733(a) of the Tariff Act of 1930 (19 
U.S.C. Sec. 1673b(a)), that there is a reasonable indication that an 
industry in the United States is materially injured by reason of 
imports from the People's Republic of China of creatine monohydrate, 
provided for in subheading 2925.20.90 of the Harmonized Tariff Schedule 
of the United States, that are alleged to be sold in the United States 
at less than fair value (LTFV).
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR Sec. 207.2(f)).
---------------------------------------------------------------------------

Commencement of Final Phase of Investigation

    Pursuant to section 207.18 of the Commission's rules, the 
Commission also gives notice of the commencement of the final phase of 
its investigation. The Commission will issue a final phase notice of 
scheduling which will be published in the Federal Register as provided 
in section 207.21 of the Commission's rules upon notice from the 
Department of Commerce (Commerce) of an affirmative preliminary 
determination in the investigation under section 733(b) of the Act, or, 
if the preliminary determination is negative, upon notice of an 
affirmative final determination in that investigation under section 
735(a) of the Act. Parties that filed entries of appearance in the 
preliminary phase of the investigation need not enter a separate 
appearance for the final phase of the investigation. Industrial users, 
and, if the merchandise under investigation is sold at the retail 
level, representative consumer organizations have the right to appear 
as parties in Commission antidumping and countervailing duty 
investigations. The Secretary will prepare a public service list 
containing the names and addresses of all persons, or their 
representatives, who are parties to the investigation.

Background

    On February 12, 1999, a petition was filed with the Commission and 
the Department of Commerce by Pfanstiehl Laboratories, Inc., Waukegan, 
IL,

[[Page 16999]]

alleging that an industry in the United States is materially injured 
and is threatened with material injury by reason of LTFV imports of 
creatine monohydrate from the People's Republic of China. Accordingly, 
effective February 12, 1999, the Commission instituted antidumping 
investigation No. 731-TA-814 (Preliminary).
    Notice of the institution of the Commission's investigation and of 
a public conference to be held in connection therewith was given by 
posting copies of the notice in the Office of the Secretary, U.S. 
International Trade Commission, Washington, DC, and by publishing the 
notice in the Federal Register of February 22, 1999 (64 FR 8629). The 
conference was held in Washington, DC, on March 8, 1999, and all 
persons who requested the opportunity were permitted to appear in 
person or by counsel.
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on April 5, 1999. The views of the 
Commission will be contained in USITC Publication 3177 (April 1999), 
entitled Creatine Monohydrate from the People's Republic of China: 
Investigation No. 731-TA-814 (Preliminary).

    Issued: March 30, 1999.

    By order of the Commission.
Donna R. Koehnke,
Secretary.
[FR Doc. 99-8604 Filed 4-6-99; 8:45 am]
BILLING CODE 7020-02-P